Immunomedics Agrees To $18M Settlement With Broker-Dealer
Immunomedics, which specializes in the treatment of cancer and autoimmune illnesses, said it reached the settlement March 27, according to a statement by the firm Monday. It did not specify which arbitration proceeding the settlement involves, referring to it only as its “previously disclosed” proceeding.
The firm has noted in its annual U.S....
To view the full article, register now.